Filter
471
Text search:
adverse
drug
event
Featured
Recommendations
65
New Publications
103
Language
Document type
No document type
255
Guidelines
86
Studies & Reports
66
Manuals
29
Strategic & Response Plan
15
Fact sheets
8
Training Material
6
Situation Updates
3
App
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
28
Western and Central Europe
23
Global
14
South Africa
13
Latin America and the Carribbean
11
Ethiopia
10
Eastern Europe
10
Nigeria
9
Uganda
9
Kenya
9
Africa
9
Ghana
8
Syria
5
Bangladesh
5
Philippines
4
Nepal
4
Tanzania
4
Rwanda
4
South–East Asia Region
4
Liberia
3
USA
3
Zimbabwe
3
Cambodia
3
Malawi
3
Namibia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Sierra Leone
2
Lesotho
2
West and Central Africa
2
Asia
2
Tajikistan
2
Congo, Democratic Republic of
1
Cameroon
1
South Sudan
1
Iraq
1
Zambia
1
China
1
Mozambique
1
Argentina
1
Eswatini/ Swaziland
1
North Macedonia
1
Ukraine
1
Botswana
1
East and Southern Africa
1
Western Pacific Region
1
Bhutan
1
Timor Leste/ East Timor
1
Russia
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
74
Public Health
27
Women & Child Health
25
Key Resources
15
Pharmacy & Technologies
12
Capacity Building
8
Toolboxes
TB
56
Mental Health
50
HIV
44
COVID-19
31
Pharmacy
23
AMR
17
Caregiver
16
NTDs
16
NCDs
10
Ebola & Marburg
9
Rapid Response
9
Planetary Health
9
Conflict
7
Specific Hazards
7
Malaria
6
Natural Hazards
5
Refugee
5
2.0 Rapid Response
5
Disability
4
Polio
4
Global Health Education
4
Cholera
2
Zika
1
Social Ethics
1
Training Workshop
Standard Treatment Guideline
The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra
...
The objective of the EMTCT Plus initiative is to achieve and sustain the elimination
of mother-to-child transmission of HIV, syphilis, Chagas, and perinatal hepatitis
B (HBV) as a public health threat. It embraces the principles and lines of action
of the Strategy for Universal Access to Health a
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international
...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I
...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients
...
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the neners. This new guide updates the 2006 edition
...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
